LMAT LEMAITRE VASCULAR INC
2026Q1 · CUSIP 525558201 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
337
Δ holders QoQ
+41
Breadth percentile
Top 6%
Whale holders
153
Δ whales
+17
Inst. holding value
$2.4B
New positions
72
Closed positions
31
Price momentum (1Q)
+13.2%
Put / Call
2/1
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 6% | — | — |
| 2024Q3 | Top 11% | -3.7% | -23.1% |
| 2024Q2 | Top 18% | +19.8% | +21.9% |
| 2024Q1 | Top 15% | +9.2% | +30.3% |
| 2023Q2 | Top 7% | -6.5% | +11.8% |
| 2022Q3 | Top 11% | +10.8% | +37.7% |
| 2020Q4 | Top 16% | +1.0% | +16.3% |
| 2019Q1 | Top 16% | +14.9% | +24.1% |
Options Sentiment
Put holders
2
QoQ: +1
Call holders
1
QoQ: +1
See methodology →
Fundamentals
PE (TTM)
37.4
EPS (TTM)
$2.72
EPS YoY
+38.1%
Revenue (TTM)
$0.3B
Revenue YoY
+13.3%
Net margin
24.3%
ROE
15.3%
Debt ratio
35.4%
FCF (TTM)
$79M
Dividend (TTM)
$0.85
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.